X4 Pharmaceuticals
XFOR
XFOR
50 hedge funds and large institutions have $113M invested in X4 Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 53 → 50 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
50
Holding in Top 10
3
Calls
$1.5M
Puts
–
Top Buyers
| 1 | +$5.02M | |
| 2 | +$3.32M | |
| 3 | +$1.53M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.53M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1M |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$4.45M | |
| 3 | -$2.02M | |
| 4 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$1.03M |
| 5 |
Millennium Management
New York
|
-$496K |